½ÃÀ庸°í¼­
»óǰÄÚµå
1654157

¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)

Pressure Monitoring Market Size, Share & Trends Analysis Report By Product (Blood Pressure Monitors, Pulmonary Pressure Monitors, Intracranial Pressure Monitors, Intraocular Pressure Monitors), By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 228¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 8.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÅüÀÇ Áß¿äÇÑ ºÎºÐÀÇ ¾Ð·Â º¯µ¿Àº Á¾Á¾ ³ì³»Àå, ½ÉÀå Áúȯ, È£Èí±â Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀ¸·Î À̾îÁý´Ï´Ù. ÀÌ ¶§¹®¿¡ ¾Ð·Â ¸ð´ÏÅ͸µ ÀåÄ¡ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¹Ì±¹ ½ÉÀåÇùȸ¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â 2014³â 7,790¸¸ ¸íÀÌ °íÇ÷¾ÐÀ» ¾Î°í ÀÖ¾ú½À´Ï´Ù. ½ÉÀå Áúȯ°ú °°Àº »ýȰ ½À°üº´À» ¾Î°í Àִ ȯÀÚ´Â Æò»ý µ¿¾È °íÇ÷¾ÐÀ» °æÇèÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ±×·¯¹Ç·Î ÀÌ·¯ÇÑ È¯ÀÚµé »çÀÌ¿¡¼­ ¾Ð·Â ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ Áõ°¡ÇÏ¿© ¾Ð·Â ¸ð´ÏÅ͸µ ÀåÄ¡ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

³ë³â Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÀÚ±ØÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ³ëÀÎ Àα¸´Â ÀϹÝÀûÀ¸·Î °íÇ÷¾ÐÀ» ¾Î°í ÀÖÀ¸¸ç ¸¸¼º Áúȯ¿¡ °É¸®±â ½±½À´Ï´Ù. ½ÉÀå Áúȯ°ú È£Èí±â ÁúȯÀ» °æÇèÇÏ´Â ÀÌ ¿¬·É´ë´Â °¡±î¿î ¹Ì·¡¿¡ ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀåÀÇ °í¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â¼úÀû Áøº¸´Â ¶ÇÇÑ »õ·Î¿î ¾Ð·Â ¸ð´ÏÅ͸µ ÀåºñÀÇ ¼Ò°³º¸´Ù ½ÃÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¸¹Àº Á¦Ç°Àº ½º¸¶Æ®Æù¿¡ ¿¬°áµÇ¾î »ç¶÷µéÀÌ ½±°Ô Ç÷¾ÐÀ» ÀÚ±â ÃøÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷Àº ³ì³»ÀåÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¾È¾ÐÀ» ÃøÁ¤ÇÏ´Â ÀåÄ¡¸¦ Á¦Á¶Çϰí ÀÖ½À´Ï´Ù.

¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Æó¾Ð ¸ð´ÏÅÍ ½ÃÀåÀº Æó °íÇ÷¾ÐÁõ ¹× ¸¸¼º Æó»ö¼º ÆóÁúȯ(COPD)°ú °°Àº ÆóÁúȯÀÇ À¯º´·ü Áõ°¡·Î 2024³â 46.3%ÀÇ ÃÖ´ë ¼öÀÍ Á¡À¯À²·Î ½ÃÀåÀ» ¼±µµÇß½À´Ï´Ù.
  • º´¿øÀº ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡¿Í ÀÔ¿øÈ¯°æ ȯ°æ¿¡¼­ ¹«Áõ»ó Ç÷¾Ð »ó½Â(BP) ÀÎ½Ä Áõ°¡·Î 2024³â 48.1%ÀÇ ÃÖ´ë ¼öÀÍ Á¡À¯À²·Î ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
  • ºÏ¹ÌÀÇ ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀåÀÌ ¼¼°è ½ÃÀåÀ» µ¶Á¡ÇßÀ¸¸ç 2024³â¿¡´Â 38.9%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå °ßÀÎ ¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå : Á¦Ç°ÀÇ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀåÀÇ Á¦Ç° º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Á¦Ç°º°(2018-2030³â)
  • Ç÷¾Ð ¸ð´ÏÅÍ
    • ¾Æ³×·ÎÀ̵å Ç÷¾Ð°è
    • µðÁöÅÐ Ç÷¾Ð°è
    • ¿Ü·¡ Ç÷¾Ð ¸ð´ÏÅÍ
    • Ç÷¾Ð Æ®·£½ºµà¼­
    • ±â±â¿Í ¾×¼¼¼­¸®
  • Æó±â¾Ð ¸ð´ÏÅÍ
    • »ê¼ÒÆ÷È­µµ ÃøÁ¤±â
    • ÆóȰ·®°è
    • Ä«ÇÁ³ë±×·¡ÇÁ
  • ¾È¾Ð ¸ð´ÏÅÍ
  • µÎ°³ ³»¾Ð ¸ð´ÏÅÍ

Á¦5Àå ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°(2018-2030³â)
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ȩ Äɾî ȯ°æ
  • ±âŸ

Á¦6Àå ¾Ð·Â ¸ð´ÏÅ͸µ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â¡¤2030³â)
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø µ¿Ç⠺м®(2018-2030³â) :
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ±â¾÷/°æÀïÀÇ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷½ÃÀå Æ÷Áö¼Å´× ºÐ¼®(2024³â)
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ/»óÀå ±â¾÷
    • Spacelabs Healthcare Inc.
    • Philips Healthcare
    • GE Healthcare
    • Welch Allyn, Inc.
    • Medtronic
    • Dragerwerk
    • Omron Healthcare Welch Allyn, Inc.
    • A&D Medical Inc.
    • SunTech Medical, Inc.
    • American Diagnostics Corp.
    • Withings
    • Rossmax International Ltd.
    • Briggs Healthcare
KTH 25.03.04

Pressure Monitoring Market Growth & Trends:

The global pressure monitoring market size is estimated to reach USD 22.8 billion by 2030, registering to grow at a CAGR of 8.7% from 2025 to 2030 according to a new report by Grand View Research, Inc. Pressure fluctuations in vital parts of the body often lead to chronic diseases such as glaucoma, cardiac disorders, and respiratory disorders. This has led to high demand for pressure monitoring devices.

According to the American Heart Association, 77.9 million people were suffering from hypertension in the U.S. in 2014. Patients suffering from lifestyle diseases like cardiac disorders are likely to experience hypertension throughout their life. Hence, there is a growing need for pressure monitoring amongst such kind of patients, thereby, increasing the demand for pressure monitoring devices.

Rising geriatric population is another significant driver stimulating the growth of the market. Aging population commonly suffers from hypertension and is highly susceptible to chronic diseases. This age group that experiences cardiac and respiratory diseases is expected to contribute toward the high growth of the pressure monitoring market in the near future.

Technological advancements are also spurring in the market due to the introduction of novel pressure monitoring devices. Many products are connected to smartphones so that people can self-monitor their blood pressure with ease. In addition, key players are manufacturing devices that measure intraocular pressure in order to reduce the risk of glaucoma.

Pressure Monitoring Market Report Highlights:

  • The pulmonary pressure monitors segment led the market with the largest revenue share of 46.3% in 2024, driven by the increasing prevalence of pulmonary diseases such as pulmonary hypertension and chronic obstructive pulmonary disease (COPD).
  • The hospitals dominated the market with the largest revenue share of 48.1% in 2024 due to the rising prevalence of chronic diseases and increasing recognition of asymptomatic elevated blood pressure (BP) in inpatient settings.
  • North America pressure monitoring market dominated the global market and accounted for a 38.9% share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Pressure Monitoring Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing hypertension cases
      • 3.2.1.2. Rising CVD incidence
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of devices
      • 3.2.2.2. Lack of reimbursement and insurance coverage
  • 3.3. Pressure Monitoring Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis

Chapter 4. Pressure Monitoring Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Pressure Monitoring Market Product Movement Analysis
  • 4.3. Global Pressure Monitoring Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Blood Pressure Monitors
    • 4.4.1. Blood pressure monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Aneroid Blood Pressure Monitors
      • 4.4.2.1. Aneroid blood pressure monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Digital Blood Pressure Monitors
      • 4.4.3.1. Digital blood pressure monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Ambulatory Blood Pressure Monitors
      • 4.4.4.1. Ambulatory blood pressure monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Blood Pressure Transducers
      • 4.4.5.1. Blood pressure transducers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Instrument & Accessories
      • 4.4.6.1. Instrument & accessories market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Pulmonary Pressure Monitors
    • 4.5.1. Pulmonary pressure monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Pulse Oximeters
      • 4.5.2.1. Pulse oximeters market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Spirometers
      • 4.5.3.1. Spirometers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Capnographs
      • 4.5.4.1. Capnographs market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Intraocular Pressure Monitors
    • 4.6.1. Intraocular pressure monitors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Intracranial Pressure Monitors
    • 4.7.1. Intracranial pressure monitors market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pressure Monitoring Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Pressure Monitoring Market End Use Movement Analysis
  • 5.3. Global Pressure Monitoring Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Surgery Centers
    • 5.5.1. Ambulatory surgery centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Home Care Settings
    • 5.6.1. Home care settings market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pressure Monitoring Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Competitive scenario
      • 6.4.1.3. Regulatory framework
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Competitive scenario
      • 6.5.7.3. Regulatory framework
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Competitive scenario
      • 6.5.8.3. Regulatory framework
      • 6.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Competitive scenario
      • 6.8.4.3. Regulatory framework
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Spacelabs Healthcare Inc.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Philips Healthcare
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. GE Healthcare
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Welch Allyn, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Medtronic
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Dragerwerk
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Omron Healthcare Welch Allyn, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. A&D Medical Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. SunTech Medical, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. American Diagnostics Corp.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Withings
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Rossmax International Ltd.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Briggs Healthcare
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦